Sabra Healthcare Reit Stock Probability of Future Stock Price Finishing Over 17.94
| SBRA Stock | USD 17.02 0.08 0.47% |
Sabra |
Sabra Healthcare Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sabra Healthcare for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sabra Healthcare REIT can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Sabra Healthcare generated a negative expected return over the last 90 days | |
| Sabra Healthcare REIT currently holds 2.45 B in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. Sabra Healthcare REIT has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Sabra Healthcare's use of debt, we should always consider it together with its cash and equity. | |
| Over 100.0% of Sabra Healthcare shares are owned by institutional investors | |
| On 29th of November 2024 Sabra Healthcare paid $ 0.3 per share dividend to its current shareholders |
Sabra Healthcare Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sabra Stock often depends not only on the future outlook of the current and potential Sabra Healthcare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sabra Healthcare's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 232.8 M | |
| Cash And Short Term Investments | 41.3 M |
Sabra Healthcare Technical Analysis
Sabra Healthcare's future price can be derived by breaking down and analyzing its technical indicators over time. Sabra Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sabra Healthcare REIT. In general, you should focus on analyzing Sabra Stock price patterns and their correlations with different microeconomic environments and drivers.
Sabra Healthcare Predictive Forecast Models
Sabra Healthcare's time-series forecasting models is one of many Sabra Healthcare's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Sabra Healthcare's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Sabra Healthcare REIT
Checking the ongoing alerts about Sabra Healthcare for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Sabra Healthcare REIT help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Sabra Healthcare generated a negative expected return over the last 90 days | |
| Sabra Healthcare REIT currently holds 2.45 B in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. Sabra Healthcare REIT has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Sabra Healthcare's use of debt, we should always consider it together with its cash and equity. | |
| Over 100.0% of Sabra Healthcare shares are owned by institutional investors | |
| On 29th of November 2024 Sabra Healthcare paid $ 0.3 per share dividend to its current shareholders |
Check out Sabra Healthcare Backtesting, Sabra Healthcare Valuation, Sabra Healthcare Correlation, Sabra Healthcare Hype Analysis, Sabra Healthcare Volatility, Sabra Healthcare History as well as Sabra Healthcare Performance. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Trading space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.